XML 40 R31.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Outstanding Warrants Activity

A summary of the Company’s outstanding warrants as of March 31, 2022, are presented below (in thousands, except share and per share amounts):

 

  

Number of

Warrants

  

Weighted

Average

Exercise Price

  

Total Intrinsic

Value

  

Weighted

Average

Remaining

Contractual Life

(in years)

 
Outstanding as of December 31, 2021   565,544   $9.96   $3,546    0.1 
Exercised   (540,541)  $9.25           
Expired   (25,000)  $9.25           
Outstanding and exercisable as of March 31, 2022   3   $24,000.00   $-    - 
Schedule of Recognized Stock-Based Compensation Expense

During the three months ended March 31, 2022 and 2021, the Company recognized stock-based compensation expense as follows:

 

   2022   2021 
   For the Three Months Ended
March 31,
 
   2022   2021 
Subscriber related  $40   $14 
Sales and marketing   8,880    713 
Technology and development   2,684    2,070 
General and administrative   7,845    6,577 
Stock-based compensation expense  $19,449   $9,374 
Schedule of Stock Option Activity

A summary of stock option activity for the three months ended March 31, 2022, is as follows (in thousands, except share and per share amounts):

 

   Number of Shares   Weighted Average
Exercise Price
   Total Intrinsic Value   Weighted Average Remaining Contractual Life
 (in years)
 
                 
Outstanding as of December 31, 2021   11,454,890   $6.40   $70,231    7.4 
Exercised   (349,847)  $1.27           
Forfeited or expired   (373,568)  $10.27           
Outstanding as of March 31, 2022   10,731,475   $6.44   $20,097    6.8 
                     
Options vested and exercisable as of March 31, 2022   7,066,665   $5.17   $18,857    6.1 
Schedule of Stock Options Assumptions

 

   March 31, 2021 
Dividend yield   0%
Expected price volatility   44.85%
Risk free interest rate   0.73%
Expected term (years)   6.1 
Schedule of Restricted Stock Unit Activity

A summary of the Company’s time-based restricted stock unit activity during the three months ended March 31, 2022 is as follows:

 

   Number of Shares  

Weighted Average

Grant-Date

Fair Value

 
Unvested at December 31, 2021   2,785,800   $25.74 
Granted   1,668,269   $7.40 
Vested   (112,326)  $27.72 
Forfeited   (84,152)  $22.15 
Unvested at March 31, 2022   4,257,591   $18.56 
Market and Service Condition Based Options [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

A summary of activity under the Plan for market and service-based stock options for the three months ended March 31, 2022 is as follows (in thousands, except share and per share amounts):

  

Number of

Shares

  

Weighted

Average

Exercise Price

  

Total Intrinsic

Value

  

Weighted

Average

Remaining

Contractual Life

(in years)

 
Outstanding as of December 31, 2021   4,453,297   $12.75   $17,933    5.7 
Outstanding as of March 31, 2022   4,453,297   $12.75   $-    5.4 
                     
Options vested and exercisable as of March 31, 2022   3,078,297   $9.69   $-    5.1 
Performance-Based Restricted Stock Units [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Restricted Stock Unit Activity

A summary of the Company’s performance-based restricted stock unit activity during the three months ended March 31, 2022 is as follows:

   Number of Shares  

Weighted Average

Grant-Date

Fair Value

 
Unvested at December 31, 2021   1,900,000   $33.87 
Vested   (280,000)  $33.87 
Unvested at March 31, 2022   1,620,000   $33.87